European Innovation Council

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Tilkal is a Paris-based company founded in 2017 that specializes in supply chain traceability and trust solutions for Industry 4.0. The company has developed a software infrastructure that organizes traceability data across various supply chain stakeholders, utilizing a unique B2B blockchain network to facilitate secure and verifiable data sharing. Tilkal's platform incorporates analytics and scoring algorithms to provide an end-to-end, real-time representation of supply chains. This enables businesses to address critical questions regarding product location, sourcing risks, ESG commitments, and compliance verification. Prominent clients include Danone, Daher, Joone, and the NGO Responsible Mica Initiative, which leverage Tilkal's capabilities for diverse applications such as tracing infant milk sourcing and analyzing mica supply chains. The Tilkal network comprises over 70 independent nodes and serves nearly 700 companies, reinforcing its role in promoting resilience, sustainability, and ethical practices within supply chains.

Nexdot is a company specializing in the development and production of semiconductor nanocrystals known as Quantum Dots, with a particular focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a renowned academic laboratory in Paris, Nexdot leverages over a decade of expertise in nanomaterial research. The company has invested four years in intensive research and development to establish unique capabilities in the synthesis of colloidal Quantum Dots and Nanoplatelets. Their proprietary materials, characterized by controlled shape and composition, are designed for a variety of applications, including displays, lighting, energy storage, detectors, and bio-imaging. Nexdot combines a team of highly skilled, passionate scientists with seasoned executives who possess a strong background in management and innovation leadership, positioning the company as a leader in the field.

Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

Qubit Pharmaceuticals is a Paris-based company established in 2020, focusing on innovative technology for pharmaceutical drug discovery. Founded by prominent academic institutions and researchers, including CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, the company leverages over 20 years of research and development. Qubit Pharmaceuticals has developed a drug discovery simulation platform that aims to significantly reduce the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform facilitates virtual screening and visualization of potential drug candidates. By integrating principles of quantum physics, Qubit Pharmaceuticals supports biopharmaceutical companies in accelerating their research and development processes, ultimately enhancing the efficiency of drug discovery.

Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.

Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

Core Biogenesis is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing next-generation recombinant protein production technologies that utilize proprietary gene editing and plant biotechnology. The company aims to significantly lower the cost of producing growth factors, which are essential molecules used in the clean meat and cell therapy industries. Core Biogenesis employs an ultra-scalable bioproduction as a service (UBaaS) platform, allowing for the efficient mass production of valuable bioproducts by using plants as biofactories. This innovative approach enhances the speed and scalability of molecule extraction while enabling clients in the healthcare sector to improve cell growth, division, and survival, ultimately increasing yields and reducing costs.

EVerZom is a nanomedicine biotech company based in Paris, France, that specializes in the large-scale manufacturing of extracellular vesicles, including exosomes, microvesicles, and apoptotic bodies. Founded in 2019, the company has developed a proprietary bioproduction platform that complies with Good Manufacturing Practice (GMP) standards, aimed at pharmaceutical companies. EVerZom's technology focuses on producing extracellular vesicles for applications in regenerative medicine and drug delivery, leveraging their protective and reparative properties. This innovative approach provides healthcare professionals with a valuable therapeutic tool to address organ failure and restore function and homeostasis in patients.

Ganymed Robotics SAS, established in 2018 and headquartered in Paris, France, specializes in the development of advanced robotics technologies tailored for orthopedic surgeons. The company's primary focus is on creating a therapeutic device designed to enhance surgical precision during knee replacement procedures. This innovative technology aims to improve patient outcomes, surgeon experience, and overall efficiency of care delivery by leveraging robotic assistance to reduce operating time.

Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.

PKvitality is a bio-wearable company based in Paris, France, that specializes in innovative health monitoring solutions. Founded in 2017, the company has developed K’Track, a line of trackers that assess key physiological markers through skin analysis, eliminating the need for blood samples. Its flagship product, K’Watch Glucose, is a continuous glucose monitoring device designed in the form of a smartwatch, featuring a micro-needle sensor that allows diabetics to monitor their glucose levels painlessly and discreetly. The device provides real-time alerts through on-body vibrations for hypo or hyperglycemic episodes, enhancing user convenience and safety. In addition to glucose monitoring, PKvitality is expanding its offerings to include continuous lactate monitoring and multi-analyte monitors, further advancing the field of wearable health technology.

Oledcomm is a Paris-based company that specializes in the design and development of LiFi solutions, which utilize light for high-speed optical wireless data communication. Founded in 2012 and re-established in February 2020 by Benjamin Azoulay, Oledcomm's product portfolio includes LiFi transceivers, software, and various solutions aimed at the aerospace and industrial markets. The company's technology offers an environmentally friendly alternative to traditional wireless communication methods, allowing for seamless connectivity across a range of applications, including telecommunications, data communications, and personal electronics. Through innovative optical networking products, Oledcomm facilitates the conversion of information into binary data, akin to an optical Morse code, enhancing the efficiency and speed of data transmission.

Aenitis Technologies is a French start-up founded in July 2014 by researchers Mauricio Hoyos and Jean-Luc Aider from the CNRS. The company specializes in the development of innovative medical devices that address challenges in cell therapy preparation and bioprocessing. Aenitis Technologies focuses on solutions for cell sorting, washing, and isolation, utilizing acoustophoresis technologies to enhance the efficiency of these processes. With an emphasis on revolutionizing practices in public health, Aenitis Technologies aims to establish itself as a world leader in the separation and filtration of biological elements, providing vital support to cell therapy units and blood banks in the healthcare industry.

Qubit Pharmaceuticals is a Paris-based company established in 2020, focusing on innovative technology for pharmaceutical drug discovery. Founded by prominent academic institutions and researchers, including CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, the company leverages over 20 years of research and development. Qubit Pharmaceuticals has developed a drug discovery simulation platform that aims to significantly reduce the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform facilitates virtual screening and visualization of potential drug candidates. By integrating principles of quantum physics, Qubit Pharmaceuticals supports biopharmaceutical companies in accelerating their research and development processes, ultimately enhancing the efficiency of drug discovery.

Oledcomm is a Paris-based company that specializes in the design and development of LiFi solutions, which utilize light for high-speed optical wireless data communication. Founded in 2012 and re-established in February 2020 by Benjamin Azoulay, Oledcomm's product portfolio includes LiFi transceivers, software, and various solutions aimed at the aerospace and industrial markets. The company's technology offers an environmentally friendly alternative to traditional wireless communication methods, allowing for seamless connectivity across a range of applications, including telecommunications, data communications, and personal electronics. Through innovative optical networking products, Oledcomm facilitates the conversion of information into binary data, akin to an optical Morse code, enhancing the efficiency and speed of data transmission.

PKvitality is a bio-wearable company based in Paris, France, that specializes in innovative health monitoring solutions. Founded in 2017, the company has developed K’Track, a line of trackers that assess key physiological markers through skin analysis, eliminating the need for blood samples. Its flagship product, K’Watch Glucose, is a continuous glucose monitoring device designed in the form of a smartwatch, featuring a micro-needle sensor that allows diabetics to monitor their glucose levels painlessly and discreetly. The device provides real-time alerts through on-body vibrations for hypo or hyperglycemic episodes, enhancing user convenience and safety. In addition to glucose monitoring, PKvitality is expanding its offerings to include continuous lactate monitoring and multi-analyte monitors, further advancing the field of wearable health technology.

Aenitis Technologies is a French start-up founded in July 2014 by researchers Mauricio Hoyos and Jean-Luc Aider from the CNRS. The company specializes in the development of innovative medical devices that address challenges in cell therapy preparation and bioprocessing. Aenitis Technologies focuses on solutions for cell sorting, washing, and isolation, utilizing acoustophoresis technologies to enhance the efficiency of these processes. With an emphasis on revolutionizing practices in public health, Aenitis Technologies aims to establish itself as a world leader in the separation and filtration of biological elements, providing vital support to cell therapy units and blood banks in the healthcare industry.